GlassScriptPhysician profile
Arun K Gupta
NPI 1245232958
$3,556.33
in general payments reported to CMS, 2019-2025
26 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $884 · 2020: $337 · 2021: $143 · 2022: $501 · 2023: $1,018 · 2024: $422 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,690.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $648.83 | 2020-2024 | Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $409.84 | 2019-2023 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $315.43 | 2019-2023 | Camzyos, Eliquis |
| Novo Nordisk INC | $294.92 | 2019-2024 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $275.37 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $246.87 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $173.07 | 2019-2022 | |
| Lilly USA, LLC | $162.00 | 2019-2025 | Kisunla, Amyvid, Jardiance |
| Allergan, INC. | $151.08 | 2019 | |
| Amgen INC. | $150.00 | 2024 | Repatha |
| Dendreon Pharmaceuticals LLC | $143.82 | 2025 | Provenge |
| Coloplast Corp | $87.50 | 2022 | |
| Tetraphase Pharmaceuticals, INC. | $79.72 | 2019 | |
| Scpharmaceuticals INC. | $68.00 | 2023 | |
| Merck Sharp & Dohme LLC | $50.30 | 2020-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $46.24 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.45 | 2020-2025 | Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $36.68 | 2022 | |
| Scilex Pharmaceuticals INC. | $31.00 | 2019 | |
| Melinta Therapeutics, LLC | $29.60 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $26.95 | 2025 | Rexulti |
| Exact Sciences Corporation | $20.30 | 2023 | Cologuard Collection Kit |
| Shire North American Group INC | $19.22 | 2019 | |
| Abbvie INC. | $18.32 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.97 | 2019 | |
| Pfizer INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.